BRCA1 and ovarian carcinoma: Previous studies in Latvia have shown that the c.181T/G mutation accounts for only 6-10% of the identified BRCA1 mutations when genetic analysis had been performed in selected early-onset breast and ovarian cancers patients [8] or in specific Latvian regions [9].